GG COLD

This brand name is authorized in Nigeria.

Active ingredients

The drug GG COLD contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII V1Q0O9OJ9Z - CHLORPHENIRAMINE MALEATE
 

Chlorphenamine is a potent antihistamine (H1-antagonist). Antihistamines diminish or abolish the actions of histamine in the body by competitive reversible blockade of histamine H1-receptor sites on tissues. Chlorphenamine also has anticholinergic activity.
 
Read more about Chlorphenamine
2
UNII 04JA59TNSJ - PHENYLEPHRINE HYDROCHLORIDE
 

Phenylephrine is a sympathomimetic agent with mainly direct effects on adrenergic receptors. It has predominantly alpha adrenergic activity and is without stimulating effects on the central nervous system. The sympathomimetic effect of phenylephrine produces vasoconstriction which in turn relieves nasal congestion.
 
Read more about Phenylephrine

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
04-9125 Capsule G. G. Cold Capsules CAP 5 mg; 4 mg 10 x 10's, 20 x 1 x 10's (in blisters) Capsule 35 RNW-PP-347025 G. G. COLD CAPSULES CHLORPHENIRAMINE MALEATE + PHENYLEPHRINE HYDROCHLORIDE EACH HARD GELATIN CAPSULE CONTAINS: PHENYLEPHRINE HYDROCHLORIDE BP 5 MG + CHLORPHENIRAMINE MALEATE BP 4 MG EXCIPIENTS: EHG.CAPS. SIZE”2” Printed GG COLD on Pink/ Clear Transparent Coloured cap/body Apr-25 Drugs Imported Products 10X10,20X1X10 OTC 8/3/2023 GENEITH PHARMACEUTICALS LIMITED, ADEWALE CRESCENT, OFF EWENLA STREET, OSHODI ISOLO LAGOS 8122912281 ngouzoamaka@yahoo.com FREDUN PHARMACEUTICAL LTD, 14,15, 16,ZORABIAN IND.COMPLEX, VILLAGE TAL. PALGHAR,THANE 401404 MAHARASHATRA STATE, India 30/11/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R06AB54 Chlorphenamine, combinations R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AB Substituted alkylamines
Discover more medicines within R06AB54

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database 04-9125

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈